Table 1.
Group | Fraction numbers (50 ml each) |
In vitro bioactivity testing assays | |||||||
---|---|---|---|---|---|---|---|---|---|
DPPH | Deoxyribose Degradation |
Reducing power | Chelating power | Lipid peroxidation | COX | Cancer | |||
SS | NSS | ||||||||
Group -1 | 01–20 | + + | + + | + + | + | + + | + + + | + + | + + + |
Group -2 | 21–55 | + + + | + + | + + | + + | + + | + + + | + + | + + |
Group -3 | 56–154 | + + + + | + + + + | + + + | + + + + | + + + | + + + + | + + + + | + + + + |
Group -4 | 155–230 | + + | + | + + | + + + | + + | + + + | + + | + + + + |
Group -5 | 231–264 | + + | + + | + | + + | + + | + + | + + + + | + + |
Group -6 | 265–488 | + + + | + + + | + + | + + + | + + + + | + + + | + + + | + + + |
Group -7 | 489–512 | + + + | + + | + + + | + + | + + | + + + | + + | + + + |
Group -8 | 513–536 | + + + + | + + + | + + | + + + | + + + | + + + | + + + + | + + + |
Group -9 | 537–563 | + + + + | + + + | + + | + + + | + + + | + + | + + + | + + + + |
Group -10 | 564–602 | + + + | + + + | + + + | + + | + + | + + + | + + + | + + + |
Group -11 | 603–692 | + + + | + + | + + | + + | + | + | + + | + + |
SS: Deoxyribose Site specific assay; NSS: Deoxyribose non-site specific assay.
Activity percentage (%) range: + : 0–25%, + + : 25–50%, + + + : 50–75%, + + + + : 75–100%.